Univariate analysis of survival outcomes for patients with glioblastoma
| Characteristic | PFS | OS | ||||
|---|---|---|---|---|---|---|
| P Value | HR | 95% CI | P Value | HR | 95% CI | |
| Age 50 years or older | .018 | 1.591 | 1.375–2.894 | .029 | 1.701 | 1.222–3.139 |
| Sex (men) | .315 | 0.764 | 0.452–1.291 | .092 | 0.631 | 0.370–1.078 |
| Preoperative KPS <80 | .015 | 2.045 | 1.165–2.445 | .038 | 2.290 | 1.267–3.835 |
| Epilepsy | .339 | 0.676 | 0.303–1.508 | .421 | 1.408 | 0.611–3.243 |
| Ringlike enhancement | .367 | 0.760 | 0.419–1.379 | .456 | 0.790 | 0.424–1.470 |
| Peritumoral edema | .304 | 1.359 | 0.757–2.439 | .232 | 1.450 | 0.788–2.667 |
| nCET | .176 | 0.696 | 0.411–1.180 | .544 | 0.847 | 0.494–1.451 |
| <GTR | .013 | 1.751 | 1.382–2.543 | .022 | 1.782 | 1.349–3.739 |
| Adjuvant therapy | .021 | 0.628 | 0.395–0.928 | .032 | 0.603 | 0.514–0.980 |
| VEGF expression +++ | .194 | 0.578 | 0.253–1.321 | .183 | 0.577 | 0.256–1.297 |